AHA: UnitedHealth report on steep specialty drug costs lets drugmakers off the hook

The American Hospital Association has called UnitedHealth's recent report on specialty drug spending in hospitals and independent practices "flawed," arguing that the authors fail to account for critical differences between care settings and fail to consider that drugmakers are the "chief culprit" in rising drug costs.